All the latest Form happenings. Want to stay in the loop? Subscribe Now
Key partnerships, breakthrough technology advancement, key leadership hires, and industry recognition demonstrate strong success
Finding reliable methods to manufacture their products is a challenge for companies specializing in cell or gene therapies. Unlike traditional small molecule or antibody drugs, these medicines involve various specialized components that must be intricately woven together through complex and costly processes.
An interview with Form Bio's Co-Founder and Co-CEO on the future of AI and the blurring boundaries between anthropomorphic and humanity and the inability to differentiate.
The AI revolution is bringing a new era of drug discovery, and the potential for more uses is greater and faster than ever before.
